Trading in Novo Nordisk shares by board members, executives and associated persons on 29 April 2016

Bagsværd, Denmark, 2 May 2016 In accordance with Section 28a of the Danish Securities Trading Act, the company's board members and executives have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons as reported by those persons to Novo Nordisk.

Further information

Anne Margrethe Hauge+45 4442
Ken Inchausti (US)+1 609 514
Peter Hugreffe Ankersen+45 3075
Daniel Bohsen+45 3079 6376
Melanie Raouzeos+45 3075 3479
Kasper Veje (US)+1 609 235

Company announcement No 35 / 2016

Company announcement No 35 / 2016

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via GlobeNewswire